Hosted on MSN3d
UnitedHealth Group posts record revenue in first report since killing of Brian Thompson
The owner of UnitedHealthcare reported record full-year revenue but lower profits for 2024, just weeks after the brazen ...
STAT2d
UnitedHealth mounts full defense of its business in wake of Thompson’s killing
UnitedHealth's CEO acknowledged discontent with the health care system, but quickly shifted the blame elsewhere.
Modern Healthcare3d
UnitedHealth to report first earnings since exec’s murder
UnitedHealth Group’s upcoming earnings call marks the company's first public appearance since the murder of UnitedHealthcare ...
Hosted on MSN2d
Brian Thompson's boss: Pharma companies are "really responsible" for drug prices
The CEO of the company whose insurance leader was killed in New York pledged to help fix the health care industry while also ...
UnitedHealth has lost $63 billion in value since former CEO Brian Thompson’s shocking murder
Despite the shocking incident, and subsequent financial loss, the company posted a better-than-expected profit in the final ...
UnitedHealth Group CEO: U.S. Health System Needs To Function Better
In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...
UnitedHealth Group aims to get back to business after CEO murder
UnitedHealth Group CEO Andrew Witty told analysts that the company is positioned well for growth in 2025. This comes just a ...
Amid scrutiny of insurance costs, UnitedHealth Group reports $5.5B quarterly profits
UnitedHealth Group has reported quarterly profits of $5.5 billion after tax in its first earnings release since the killing ...
UnitedHealth Group 2024 Profits Hit $14 Billion Despite Cyberattack, Rising Costs
UnitedHealth Group reported $14.4 billion in 2024 profits as its UnitedHealthcare health insurance and Optum provider ...
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...